Endocarditis After Transcatheter Pulmonary Valve Replacement.

[1]  L. Køber,et al.  Incidence of infective endocarditis among patients considered at high risk , 2018, European heart journal.

[2]  H. Laks,et al.  Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  K. Dimopoulos,et al.  Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015 , 2017, PloS one.

[4]  J. Riou,et al.  Infective Endocarditis Risk After Percutaneous Pulmonary Valve Implantation With the Melody and Sapien Valves. , 2017, JACC. Cardiovascular interventions.

[5]  D. McElhinney.  Reflection and Rationalization: Making Sense of the Literature on Endocarditis After Transcatheter Pulmonary Valve Replacement , 2017, Circulation. Cardiovascular interventions.

[6]  P. Ewert,et al.  Five-year results from a prospective multicentre study of percutaneous pulmonary valve implantation demonstrate sustained removal of significant pulmonary regurgitation, improved right ventricular outflow tract obstruction and improved quality of life. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[7]  A. Zwinderman,et al.  Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material , 2017, European heart journal.

[8]  J. Rome,et al.  Transcatheter Pulmonary Valve Replacement Reduces Tricuspid Regurgitation in Patients With Right Ventricular Volume/Pressure Overload. , 2016, Journal of the American College of Cardiology.

[9]  L. Baddour,et al.  Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults. , 2016, European heart journal cardiovascular Imaging.

[10]  N. Wilson,et al.  Infective endocarditis following Melody valve implantation: comparison with a surgical cohort , 2016, Cardiology in the Young.

[11]  C. Fraser,et al.  Risk factors for development of endocarditis and reintervention in patients undergoing right ventricle to pulmonary artery valved conduit placement. , 2016, The Journal of thoracic and cardiovascular surgery.

[12]  E. Tuzcu,et al.  Response to Letters Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry". , 2015, Circulation.

[13]  R. Baltimore,et al.  Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association , 2015, Circulation.

[14]  S. Pasquali,et al.  The Utility of Intracardiac Echocardiography Following Melody™ Transcatheter Pulmonary Valve Implantation , 2015, Pediatric Cardiology.

[15]  M. Jacobs,et al.  Benchmark Outcomes for Pulmonary Valve Replacement Using The Society of Thoracic Surgeons Databases. , 2015, The Annals of thoracic surgery.

[16]  J. Cheatham,et al.  Clinical and Hemodynamic Outcomes up to 7 Years After Transcatheter Pulmonary Valve Replacement in the US Melody Valve Investigational Device Exemption Trial , 2015, Circulation.

[17]  H. Bundgaard,et al.  Prosthetic Valve Endocarditis After Transcatheter Aortic Valve Implantation , 2015, Circulation. Cardiovascular interventions.

[18]  B. Eyskens,et al.  Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants , 2014, Heart.

[19]  L. Iserin,et al.  Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation. , 2014, The Journal of thoracic and cardiovascular surgery.

[20]  J. Rome,et al.  One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study. , 2014, JACC. Cardiovascular interventions.

[21]  M. Chen,et al.  Effects of transcatheter pulmonary valve replacement on the hemodynamic and ventricular response to exercise in patients with obstructed right ventricle-to-pulmonary artery conduits. , 2014, JACC. Cardiovascular interventions.

[22]  H. Bundgaard,et al.  Infective endocarditis following percutaneous pulmonary valve replacement: diagnostic challenges and application of intra-cardiac echocardiography. , 2013, International journal of cardiology.

[23]  J. Cheatham,et al.  The medtronic melody® transcatheter pulmonary valve implanted at 24‐mm diameter—it works , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  J. Kaufman,et al.  Infective Endocarditis in Children With Congenital Heart Disease: Cumulative Incidence and Predictors , 2013, Circulation.

[25]  D. Raoult,et al.  Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. , 2013, Journal of the American College of Cardiology.

[26]  D. McElhinney,et al.  Infective Endocarditis After Transcatheter Pulmonary Valve Replacement Using the Melody Valve: Combined Results of 3 Prospective North American and European Studies , 2013, Circulation. Cardiovascular interventions.

[27]  K. Gauvreau,et al.  Bloodstream Infections Occurring in Patients With Percutaneously Implanted Bioprosthetic Pulmonary Valve: A Single-center Experience , 2013, Circulation. Cardiovascular Interventions.

[28]  L. Iserin,et al.  Atypical malignant late infective endocarditis of Melody valve. , 2012, The Journal of thoracic and cardiovascular surgery.

[29]  J. Cheatham,et al.  Short- and Medium-Term Outcomes After Transcatheter Pulmonary Valve Placement in the Expanded Multicenter US Melody Valve Trial , 2010, Circulation.

[30]  R. Weber,et al.  Interventions Using Foreign Material to Treat Congenital Heart Disease in Children Increase the Risk for Infective Endocarditis , 2008, The Pediatric infectious disease journal.

[31]  R. Razavi,et al.  Percutaneous Pulmonary Valve Implantation in Humans: Results in 59 Consecutive Patients , 2005, Circulation.

[32]  P. Bonhoeffer,et al.  Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction , 2000, The Lancet.

[33]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  W. Foss,et al.  Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis , 1996, Infection and immunity.

[35]  S. Jockenhoevel,et al.  Bacterial adherence to graft tissues in static and flow conditions , 2018, The Journal of thoracic and cardiovascular surgery.

[36]  V. Rousson,et al.  Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans? , 2015, The Journal of infectious diseases.

[37]  G. Stein,et al.  Positron emission tomography/computed tomography for the diagnosis of endocarditis in patients with pulmonic stented valve/pulmonic stent. , 2011, The Annals of thoracic surgery.